For clinicians weighing Azzalure vs Botox, the decision often comes down to unit conversion, onset, and how each product fits an existing treatment protocol. Both are botulinum toxin type A formulations that temporarily relax the muscles behind glabellar lines. However, they differ in dosing, dilution, and price, so switching between them isn’t a simple swap.
Medica Depot’s guide walks through how Azzalure and Botox measure up so providers can weigh them with confidence. This article compares Azzalure vs Botox across mechanism of action, unit concentrations, onset and diffusion, pricing, and the practical factors that go into choosing between them.
For providers looking to buy Azzalure, consistently review current product specifications and manufacturer documentation.
Key Takeaways
- Azzalure and Botox are both botulinum toxin type A products, but their potency units (Speywood units vs. Allergan units) are not interchangeable on a 1:1 basis.
- Published conversion estimates place the Azzalure-to-Botox ratio at roughly 2.5:1 to 3:1, though this figure comes largely from non-aesthetic studies.
- Differences in onset, diffusion, and price are a matter of degree, not category, and providers weigh them alongside patient anatomy and treatment goals rather than treating one product as universally superior.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. We offer a worry-free experience in searching for the best and most popular products on the market, like Azzalure. Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
Azzalure vs Botox Comparison: An Overview
Azzalure and Botox are both classified as botulinum toxin type A, derived from the same bacterium, Clostridium botulinum, but manufactured and standardized differently. Azzalure (abobotulinumtoxinA) is manufactured by Ipsen and distributed by Galderma across much of Europe. Botox (onabotulinumtoxinA), by contrast, is manufactured by Allergan, an AbbVie company [3][4]. Whether framed as Azzalure and Botox or Botox and Azzalure, providers are ultimately comparing two variations on the same drug class.
Both fall under the umbrella of anti-wrinkle injection treatments used to address dynamic facial lines, and both are approved for the temporary improvement of moderate-to-severe glabellar lines in appropriately assessed adult patients. Providers weighing this comparison often find that knowing what Azzalure is at the formulation level, including its manufacturer standardization and Speywood-unit measurement, clarifies why so many of the downstream differences with Botox exist at all.
Because Azzalure and Botox come from different production processes, they use different potency-unit systems, and that difference shapes nearly every other point of comparison in this article. It ripples out to dosing, diffusion, and pricing. Providers can weigh a broader range of options on the botulinum toxin type A category page for related formulations.
How Do Azzalure and Botox Work as Neuromodulators?
Mechanistically, Azzalure and Botox work the same way. Each product temporarily blocks acetylcholine release at the neuromuscular junction, interrupting the nerve signal that would otherwise trigger muscle contraction [3]. Because the muscle can’t contract fully, the overlying skin smooths out, reducing the appearance of wrinkles and softening fine lines caused by repeated muscle movement, such as frowning.
This shared mechanism is why both products are grouped as neuromodulators rather than dermal fillers. They act on muscle activity rather than adding volume. The practical differences between Azzalure and Botox emerge not from how they work, but from how much product is needed to achieve that effect and how quickly the effect becomes noticeable.
How Do Their Units and Concentrations Differ?
Azzalure is supplied in 125 Speywood-unit vials and is typically reconstituted to around 200 Speywood units per mL, with a recommended total dose of 50 Speywood units for glabellar lines, delivered as 10 units across five injection points [1][3].
Botox, by contrast, is supplied in 50- or 100-unit vials (measured in Allergan/onabotulinumtoxinA units) and is dosed at a total of 20 units for the same indication, delivered as 4 units across five injection points [4].
Critically, Speywood units and Allergan units are not the same thing, and product labeling for both explicitly states that units are not interchangeable between botulinum toxin preparations [3][4]. Published conversion ratios for Azzalure-to-Botox dosing generally fall around a 2.5:1 ratio. However, this data comes largely from non-aesthetic indications such as cervical dystonia rather than head-to-head aesthetic trials [5]. In practice, a provider switching a patient from one product to the other needs to recalculate dosing rather than substitute unit for unit.
When Do Azzalure and Botox Results Begin to Appear?
Some clinical reports indicate that Azzalure may begin affecting muscle activity within hours of injection for some patients. Across studies, however, the more consistent finding is onset within 24 hours, with a median onset around 2–4 days. Separate Botox studies have found that many patients notice results within the first one to two days.
Diffusion, which describes how far the toxin spreads from the injection site, is often cited as a reason Azzalure behaves differently from Botox. Some clinicians report that Azzalure’s larger reconstitution volume leads to a wider spread.
Dermatology researchers who have examined this question directly, however, have found the evidence inconsistent. Some studies show no measurable difference in spread to adjacent muscles between the two toxin types [5]. Providers should treat diffusion as a factor to manage through careful dilution and injection technique rather than as a fixed, predictable difference between the brands.
Which Factors Affect the Cost of Azzalure vs Botox?
Azzalure vs Botox price comparisons are complicated because neither product is billed to patients per vial. Their pricing is almost always calculated per unit or per treatment area, and wholesale cost varies by supplier, order volume, and region. Because Azzalure and Botox use different unit systems and different total-dose requirements for the same indication, a lower per-unit wholesale cost for one product does not automatically translate into a lower per-treatment cost.
The number of units required to achieve a clinical effect matters as much as the per-unit price. Practitioners should also note that vial size is a practical consideration with these treatments. Azzalure’s 125-Speywood-unit vials suit clinics treating a reasonable volume of patients in a single session, while Botox’s smaller 50- or 100-unit vial options can reduce wastage for practices with lower daily patient volume [3][4].
Providers comparing overall cost per treatment should factor in both the unit price and the total units needed to reach the recommended dose for the indication being treated.
Sourcing Considerations for Clinics That Buy Azzalure Wholesale
Beyond vial sizing, clinics that buy Azzalure wholesale should verify cold-chain shipping documentation across the transit chain, since Azzalure’s stability depends on maintaining the 2–8°C range through delivery.
Requirements to purchase Azzalure online vary by jurisdiction, and licensed professionals evaluating where to buy Azzalure online for the first time should check what their regional regulations permit before ordering from any supplier. Ongoing shipping arrangements should include documented temperature logs, and providers weighing a new distributor may want to compare cold-chain policies alongside pricing when they buy Azzalure wholesale for their practice.
What Should Providers Consider When Choosing Azzalure or Botox?
Bringing the Azzalure vs Botox differences together, the factors that most influence an informed decision include:
- Concentration and unit system: Azzalure is dosed in Speywood units at higher total unit counts; Botox is dosed in a separate unit system at lower total unit counts for the same indication.
- Diffusion: Current evidence does not consistently support one product spreading further than the other.
- Price: Cost per treatment depends on unit pricing and the total units required for a treatment plan, not vial price alone.
- Injection site and technique: Both products target the same muscles for glabellar lines, but dosing per point differs based on the unit system in use.
None of these differences between Botox and Azzalure make one product categorically better than the other. Instead, they inform how a provider tailors technique, dosing, and patient conversations to the product they have selected, always supporting the patient’s aesthetic goals and an informed decision reached collaboratively with the patient.
When Might a Provider Choose Azzalure Over Botox?
The choice between Azzalure vs Botox often comes down to provider familiarity, patient history, and supply considerations. Individualized treatment plans tend to serve each patient’s specific concerns more effectively than a one-product-fits-all approach.
A provider already experienced with Speywood-unit dosing may find Azzalure a natural fit for glabellar line treatment. Its slightly faster reported onset for some patients can matter in workflows where speed to visible effect factors into the patient conversation. Practitioners more accustomed to Allergan’s unit system, or treating a patient with a documented history of one product, may reasonably continue with Botox for consistency.
In our experience, provider familiarity with a given unit system often becomes the deciding factor, more than any documented difference in the products themselves. A practice that has run Botox for years builds intuition for its 4-unit-per-point dosing that does not transfer cleanly to Speywood units. That transition friction is real, and it is a legitimate reason to stay with a familiar product even when a switch might look attractive on a per-unit price sheet.
Ultimately, any Azzalure vs Botox comparison should end in the same place: make the final decision with a qualified professional who can assess the patient’s anatomy, muscle strength, and aesthetic goals, and weigh both products as an effective option in the right context.
Looking to buy Azzalure online? Get in touch with Medica Depot’s support representatives for further guidance.
The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.
Citations
[1] Ascher, B et al. “International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)–Part I: Upper facial wrinkles.” Journal of the European Academy of Dermatology and Venereology : JEADV vol. 24,11 (2010): 1278-84. doi:10.1111/j.1468-3083.2010.03631.x
[2] Rzany, Berthold et al. “Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.” Journal of drugs in dermatology : JDD vol. 12,1 (2013): 80-4.
[3] Galderma (U.K.) Limited. “Azzalure, 125 Speywood Units, Powder for Solution for Injection: Summary of Product Characteristics (SmPC).” electronic Medicines Compendium (emc), 12 Feb. 2026, www.medicines.org.uk/emc/product/6584/smpc.
[4] AbbVie Inc. “BOTOX® Cosmetic (OnabotulinumtoxinA) for Injection, for Intramuscular Use: Full Prescribing Information.” AbbVie, revised Oct. 2024, www.rxabbvie.com/pdf/botox-cosmetic_pi.pdf.
[5] “Botox, Dysport Share More Similarities than Differences, Studies Show.” Dermatology Times, 1 July 2011, www.dermatologytimes.com/view/botox-dysport-share-more-similarities-differences-studies-show.
This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.
